Literature DB >> 21723463

MRI features of 4 female patients with pyruvate dehydrogenase E1 alpha deficiency.

Nicholas Ah Mew1, Johanna B Loewenstein, Nadja Kadom, Uta Lichter-Konecki, Andrea L Gropman, Jodie M Martin, Adeline Vanderver.   

Abstract

Pyruvate dehydrogenase complex is a key intramitochondrial multienzyme complex required for the conversion of pyruvate to acetyl-CoA. Most patients with pyruvate dehydrogenase deficiency have a defect in the E1 alpha subunit, associated with mutations in the PDHA1 gene. In this report, we submit detailed magnetic resonance images in 4 affected female patients with PDHA1 mutations who had with severe cortical atrophy, dilated ventricles, and an incomplete corpus callosum. In one of these patients, the magnetic resonance imaging pattern prompted molecular diagnostic testing when enzymatic testing was normal. We underscore that this constellation of features, which may be misdiagnosed as periventricular leukomalacia, illustrates a pattern highly suggestive of a deficiency of pyruvate dehydrogenase E1 alpha in female patients and should trigger appropriate diagnostic investigations. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723463      PMCID: PMC3129538          DOI: 10.1016/j.pediatrneurol.2011.02.003

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  22 in total

Review 1.  Molecular biology and biochemistry of pyruvate dehydrogenase complexes.

Authors:  M S Patel; T E Roche
Journal:  FASEB J       Date:  1990-11       Impact factor: 5.191

2.  The large temporal horn: MR analysis in developmental brain anomalies versus hydrocephalus.

Authors:  L L Baker; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jan-Feb       Impact factor: 3.825

Review 3.  Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency.

Authors:  W Lissens; L De Meirleir; S Seneca; I Liebaers; G K Brown; R M Brown; M Ito; E Naito; Y Kuroda; D S Kerr; I D Wexler; M S Patel; B H Robinson; A Seyda
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

Review 4.  Defects of pyruvate metabolism and the Krebs cycle.

Authors:  Linda De Meirleir
Journal:  J Child Neurol       Date:  2002-12       Impact factor: 1.987

5.  Neuropathological findings of a patient with pyruvate dehydrogenase E1 alpha deficiency presenting as a cerebral lactic acidosis.

Authors:  A Michotte; L De Meirleir; W Lissens; R Denis; J L Wayenberg; I Liebaers; J M Brucher
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Pyruvate dehydrogenase E1alpha subunit deficiency in a female patient: evidence of antenatal origin of brain damage and possible etiology of infantile spasms.

Authors:  Naoko Wada; Toyojiro Matsuishi; Michiko Nonaka; Etsuo Naito; Makoto Yoshino
Journal:  Brain Dev       Date:  2004-01       Impact factor: 1.961

7.  Pyruvate dehydrogenase deficiency: clinical and biochemical diagnosis.

Authors:  L De Meirleir; W Lissens; R Denis; J L Wayenberg; A Michotte; J M Brucher; E Vamos; E Gerlo; I Liebaers
Journal:  Pediatr Neurol       Date:  1993 May-Jun       Impact factor: 3.372

8.  Phase-contrast MRI and 3D-CISS versus contrast-enhanced MR cisternography on the evaluation of the aqueductal stenosis.

Authors:  Oktay Algin; Bahattin Hakyemez; Mufit Parlak
Journal:  Neuroradiology       Date:  2009-09-15       Impact factor: 2.804

Review 9.  Mutations and polymorphisms in the pyruvate dehydrogenase E1 alpha gene.

Authors:  H H Dahl; G K Brown; R M Brown; L L Hansen; D S Kerr; I D Wexler; M S Patel; L De Meirleir; W Lissens; K Chun
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

10.  Clinical diversity of pyruvate dehydrogenase deficiency.

Authors:  J H Cross; A Connelly; D G Gadian; B E Kendall; G K Brown; R M Brown; J V Leonard
Journal:  Pediatr Neurol       Date:  1994-06       Impact factor: 3.372

View more
  3 in total

Review 1.  The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders.

Authors:  Wolfgang Sperl; Leanne Fleuren; Peter Freisinger; Tobias B Haack; Antonia Ribes; René G Feichtinger; Richard J Rodenburg; Franz A Zimmermann; Johannes Koch; Isabel Rivera; Holger Prokisch; Jan A Smeitink; Johannes A Mayr
Journal:  J Inherit Metab Dis       Date:  2014-12-20       Impact factor: 4.982

2.  Missense variants in the middle domain of DNM1L in cases of infantile encephalopathy alter peroxisomes and mitochondria when assayed in Drosophila.

Authors:  Yu-Hsin Chao; Laurie A Robak; Fan Xia; Mary K Koenig; Adekunle Adesina; Carlos A Bacino; Fernando Scaglia; Hugo J Bellen; Michael F Wangler
Journal:  Hum Mol Genet       Date:  2016-02-29       Impact factor: 6.150

3.  Identification of solute carrier family genes related to the prognosis and tumor-infiltrating immune cells of pancreatic ductal adenocarcinoma.

Authors:  Yuhua Meng; Yanting Li; Dalang Fang; Yuanlu Huang
Journal:  Ann Transl Med       Date:  2022-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.